These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 18060781)

  • 21. Prognostic value of extracapsular extension of axillary lymph node metastases in T1 to T3 breast cancer.
    Neri A; Marrelli D; Roviello F; De Stefano A; Guarnieri A; Pallucca E; Pinto E
    Ann Surg Oncol; 2005 Mar; 12(3):246-53. PubMed ID: 15827817
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical significance of axillary nodal ratio in stage II/III breast cancer treated with neoadjuvant chemotherapy.
    Keam B; Im SA; Kim HJ; Oh DY; Kim JH; Lee SH; Chie EK; Han W; Kim DW; Cho N; Moon WK; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
    Breast Cancer Res Treat; 2009 Jul; 116(1):153-60. PubMed ID: 18787948
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognosis and management of patients with node-negative invasive breast carcinoma that is 1 cm or smaller in size (stage 1; T1a,bN0M0): a review of the literature.
    Hanrahan EO; Valero V; Gonzalez-Angulo AM; Hortobagyi GN
    J Clin Oncol; 2006 May; 24(13):2113-22. PubMed ID: 16648513
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic value of lymphovascular invasion in women with lymph node negative invasive breast carcinoma.
    Lee AH; Pinder SE; Macmillan RD; Mitchell M; Ellis IO; Elston CW; Blamey RW
    Eur J Cancer; 2006 Feb; 42(3):357-62. PubMed ID: 16377180
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patients with t1 to t2 breast cancer with one to three positive nodes have higher local and regional recurrence risks compared with node-negative patients after breast-conserving surgery and whole-breast radiotherapy.
    Truong PT; Jones SO; Kader HA; Wai ES; Speers CH; Alexander AS; Olivotto IA
    Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):357-64. PubMed ID: 18676091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anemia is a significant prognostic factor in local relapse-free survival of premenopausal primary breast cancer patients receiving adjuvant cyclophosphamide/methotrexate/5-fluorouracil chemotherapy.
    Dubsky P; Sevelda P; Jakesz R; Hausmaninger H; Samonigg H; Seifert M; Denison U; Mlineritsch B; Steger G; Kwasny W; Stöger H; Bartsch R; Stierer M; Taucher S; Fridrik M; Schippinger W; Greil R; Pötter R; Gnant M;
    Clin Cancer Res; 2008 Apr; 14(7):2082-7. PubMed ID: 18381948
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Locoregional recurrence rates and prognostic factors for failure in node-negative patients treated with mastectomy: implications for postmastectomy radiation.
    Jagsi R; Raad RA; Goldberg S; Sullivan T; Michaelson J; Powell SN; Taghian AG
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1035-9. PubMed ID: 15990006
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic significance of lymphovascular invasion diagnosed by lymphatic endothelium immunostaining in breast cancer patients.
    Tezuka K; Onoda N; Takashima T; Takagaki K; Ishikawa T; Wakasa T; Wakasa K; Hirakawa K
    Oncol Rep; 2007 May; 17(5):997-1003. PubMed ID: 17390035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The treatment outcome of patients undergoing breast-conserving therapy: the clinical role of postoperative radiotherapy.
    Oouchi A; Sakata K; Masuoka H; Tamakawa M; Nagakura H; Someya M; Nakata K; Asaishi K; Okazaki M; Okazaki Y; Ohmura T; Hareyama M; Hori M; Shimokawara I; Okazaki A; Watanabe Y; Yamada T; Yuyama T; Satoh T; Hirata K
    Breast Cancer; 2009; 16(1):49-57. PubMed ID: 18841332
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term outcome with interstitial brachytherapy boost in the treatment of women with early-stage breast cancer.
    Neumanova R; Petera J; Frgala T; Dusek L; Jarkovsky J; Kuricka R
    Neoplasma; 2007; 54(5):413-23. PubMed ID: 17688371
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinicopathologic study associated with long-term survival in Japanese patients with node-negative breast cancer.
    Kato T; Kimura T; Miyakawa R; Fujii A; Yamamoto K; Kameoka S; Nishikawa T; Kasajima T
    Br J Cancer; 2000 Jan; 82(2):404-11. PubMed ID: 10646896
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A tool for predicting breast carcinoma mortality in women who do not receive adjuvant therapy.
    Kattan MW; Giri D; Panageas KS; Hummer A; Cranor M; Van Zee KJ; Hudis CA; Norton L; Borgen PI; Tan LK
    Cancer; 2004 Dec; 101(11):2509-15. PubMed ID: 15495180
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lymphatic space invasion is not an independent predictor of outcomes in early stage breast cancer treated by breast-conserving surgery and radiation.
    Freedman GM; Li T; Polli LV; Anderson PR; Bleicher RJ; Sigurdson E; Swaby R; Dushkin H; Patchefsky A; Goldstein L
    Breast J; 2012 Sep; 18(5):415-9. PubMed ID: 22776042
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is it useful to detect lymphovascular invasion in lymph node-positive patients with primary operable breast cancer?
    Ragage F; Debled M; MacGrogan G; Brouste V; Desrousseaux M; Soubeyran I; de Lara CT; Mauriac L; de Mascarel I
    Cancer; 2010 Jul; 116(13):3093-101. PubMed ID: 20564641
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic factors affecting the natural history of node-negative breast cancer.
    Trudeau ME; Pritchard KI; Chapman JA; Hanna WM; Kahn HJ; Murray D; Sawka CA; Mobbs BG; Andrulis I; McCready DR; Lickley HL
    Breast Cancer Res Treat; 2005 Jan; 89(1):35-45. PubMed ID: 15666195
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Can a subgroup of node-negative breast carcinoma patients with T1-2 tumor who may benefit from postmastectomy radiotherapy be identified?
    Yildirim E; Berberoglu U
    Int J Radiat Oncol Biol Phys; 2007 Jul; 68(4):1024-9. PubMed ID: 17398017
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Breast cancer patients with 10 or more involved axillary lymph nodes treated by multimodality therapy: influence of clinical presentation on outcome.
    Geara FB; Nasr E; Tucker SL; Charafeddine M; Dabaja B; Eid T; Abbas J; Salem Z; Shamseddine A; Issa P; El Saghir N
    Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):364-9. PubMed ID: 17324529
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of lymphovascular invasion in early breast cancer by D2-40 (podoplanin): a clinically useful predictor for axillary lymph node metastases.
    Braun M; Flucke U; Debald M; Walgenbach-Bruenagel G; Walgenbach KJ; Höller T; Pölcher M; Wolfgarten M; Sauerwald A; Keyver-Paik M; Kühr M; Büttner R; Kuhn W
    Breast Cancer Res Treat; 2008 Dec; 112(3):503-11. PubMed ID: 18165897
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Locoregional recurrence risks in elderly breast cancer patients treated with mastectomy without adjuvant radiotherapy.
    Truong PT; Lee J; Kader HA; Speers CH; Olivotto IA
    Eur J Cancer; 2005 Jun; 41(9):1267-77. PubMed ID: 15939262
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Local control in 118 consecutive high-risk breast cancer patients treated with breast-conserving therapy.
    Vordermark D; Lackenbauer A; Wulf J; Guckenberger M; Flentje M
    Oncol Rep; 2007 Nov; 18(5):1335-9. PubMed ID: 17914594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.